Department of Cardiovascular and Neurological Sciences, University of Cagliari, Sardinia, Italy.
J Cardiovasc Med (Hagerstown). 2010 Mar;11(3):207-20. doi: 10.2459/JCM.0b013e32833178ed.
This article addresses the various aspects concerning gender dissimilarities in the cardiovascular system. It examines sex differences in the genetic susceptibility to cardiovascular disease (CVD) development or outcome: with the presence of either XX or XY chromosomes, every cell is sexually differentiated and there exist postpuberal differences between male and female cardiovascular systems. The main action mechanisms of sex steroid hormones are discussed, mainly as to testosterone (Te) in men and 17beta-estradiol (E2) and progesterone (Pro) in women. In women, susceptibility to CVD is known to increase in the postmenopausal period, when the ovarian hormone function expires. Some concepts of the sex-based differences in anatomy and physiology are also explained. Although they have the same structural elements, women and men use them in a different way to guarantee cardiovascular system homeostasis. Some examples of differences between men and women in pathological cardiovascular function are given. A further important issue regards the prevalence and role of cardiovascular risk factors in the two genders. Compared to boys of the same age, adolescent girls and premenopausal women have a more favorable risk profile: lower blood pressure (BP), less atherogenic lipid profile, and lower prevalence of cardiovascular risk factors. Women develop CVD later than men and diabetic women have a considerably higher mortality rate compared to men of the same age. Finally, there exist several clinically significant differences between men and women as to prevalence, presentation, management and outcome of CVD. Clinical peculiarities related to gender in presentation of some CVDs, such as coronary heart disease (CHD), stroke and heart failure, are described. We are absolutely convinced that only an accurate knowledge of the sex-specific pathophysiology may allow determination of the appropriate diagnostic instruments and to implement tailored treatments of CVD in men and women.
这篇文章涉及心血管系统中性别差异的各个方面。它检查了心血管疾病 (CVD) 发展或结果的遗传易感性中的性别差异:XX 或 XY 染色体的存在使每个细胞具有性别差异,并且男性和女性心血管系统存在青春期后差异。讨论了性激素的主要作用机制,主要是男性的睾酮 (Te) 和女性的 17β-雌二醇 (E2) 和孕酮 (Pro)。众所周知,女性在绝经后 CVD 的易感性增加,此时卵巢激素功能丧失。还解释了一些基于性别的解剖和生理学差异的概念。尽管它们具有相同的结构元素,但女性和男性以不同的方式使用它们来保证心血管系统的内稳态。给出了一些男性和女性在病理性心血管功能上的差异示例。另一个重要问题是心血管危险因素在两性中的流行和作用。与同龄男孩相比,青春期女孩和绝经前妇女具有更有利的风险特征:血压 (BP) 较低、致动脉粥样硬化的血脂谱较低以及心血管危险因素的患病率较低。女性比男性晚发生 CVD,并且同龄男性相比,糖尿病女性的死亡率高得多。最后,男女之间存在一些与 CVD 的流行、表现、管理和结果相关的临床显著差异。描述了一些 CVD 如冠心病 (CHD)、中风和心力衰竭的临床表现中与性别相关的临床特征。我们完全相信,只有准确了解性别特异性病理生理学,才能确定适当的诊断工具,并对男性和女性的 CVD 实施针对性治疗。